Last updated on October 2018

Haplo SCT vs Haplo-cord SCT for Patients With Hematological Disorders

Brief description of study

Patients who have hematological disorders and will undergo haplo-identical donor stem cell transplantation (haplo SCT) are candidates of this trial. Participants will randomized into two arms: Arm A will undergo a typical haplo SCT, while Arm B will receive an co-infusion of an unrelated cord blood unit (haplo-cord SCT) in addition to Arm A. Overall survival, progression-free survival, nonrelapse mortality and cumulative incidence of relapse will be recorded and endpoints.

Clinical Study Identifier: NCT03719534

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.